Dibash Kumar Das, PhD

Researchers evaluated the correlation of nail videocapillaroscopy patterns and digital thermal monitoring variables in systemic sclerosis.

The American College of Rheumatology has issued clinical guidance to rheumatology providers for the management of pediatric patients with rheumatic disease during the COVID-19 pandemic.

Researchers evaluated the prevalence of hospital-diagnosed COVID-19 in chronic inflammatory and autoimmune rheumatic diseases.

Researchers determined the effect of treatment with cyclophosphamide and mycophenolate mofetil on patient-reported outcomes in systemic sclerosis-related interstitial lung disease.

Researchers evaluated anticentromere and -topoisomerase antibody-specific isotype expression and organ involvement associated with the degree of microangiopathy in systemic sclerosis.

Authors of this viewpoint described the current challenges in the management of cytokine storm syndromes and reviewed the safety profile of intravenous anakinra.

A EULAR task force developed recommendations for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy.

Researchers evaluated the association between trabecular bone score and new bone formation in ankylosing spondylitis.

Researchers described the frequency of rheumatic regional pain syndromes in first-degree relatives of patients with rheumatoid arthritis.

Researchers compared the 3 diagnostic criteria and assessed the performance of an additional set of criteria in the diagnosis of fibromyalgia.

An increase in hospitalizations for acute myocardial infarction-rheumatoid arthritis was observed between 2002 and 2016, with rheumatoid arthritis found to be independently associated with lower in-hospital mortality in patients with acute myocardial infarction.

Investigators characterized the effects and markers of response of omalizumab in normocomplementemic urticarial vasculitis.

The World Scleroderma Foundation developed preliminary guidance based on clinical questions on the SARS-CoV-2 infection for systemic sclerosis management during COVID-19.

Researchers evaluated the association between systemic sclerosis (SSc) and ischemic stroke, and determined risk factors for cerebrovascular accidents in SSc.

Researchers examined the changes in the presentation of incident gout in the last
20 years and determined risk for subsequent gout flares after an initial gout attack.

Researchers of this editorial have discussed the importance of flu vaccination among patients with rheumatic diseases.

The American College of Rheumatology developed recommendations for decision-making to distinguish between the need for in-person urgent and virtual nonurgent medical care.

Researchers investigated whether the influenza vaccine was effective in preventing respiratory morbidity, mortality, and all-cause mortality in patients with autoimmune rheumatic diseases.

Researchers assessed wait times at a single center for patients with juvenile idiopathic arthritis and described factors associated with longer wait times.

Italy’s health care system is highly regarded, having more hospital beds per capita than the United States.

Researchers assessed the incidence of isotretinoin-triggered axial spondyloarthropathy in acne vulgaris patients based on clinical features and MRI findings and examined clinical and radiologic outcomes after drug withdrawal.

Researchers examined the effect of intravenous cyclophosphamide pulse therapy on skin thickening in patients with systemic sclerosis.

Researchers described the clinical characteristics and outcomes of systemic sclerosis (SSc)-mixed connective tissue disease and SSc-overlap.

Investigators assessed the effectiveness of anakinra and canakinumab in patients with familial Mediterranean fever who were resistant/intolerant to colchicine or who had complications with amyloidosis.

Researchers reported on the outcomes of treatment-refractory, corticosteroid-dependent patients with eosinophilic granulomatosis with polyangiitis with severe asthma.

Researchers assessed the effect of uveitis, psoriasis, and inflammatory bowel disease on disease activity and functional status in a population-based cohort of patients with axial spondyloarthritis.

The study, presented at the American Society for Bone and Mineral Research 2019 Annual Meeting, described the experience of patients who initiated treatment with abaloparatide.